Polygenic liability for antipsychotic dosage and polypharmacy - a real-world registry and biobank study. Koch E, Kampe A, Alver M, Siguretharson S, et al. Neuropsychopharmacology 2024;49:1113-1119.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Koch E, Kampe A, Alver M, Siguretharson S, et al. Polygenic liability for antipsychotic dosage and polypharmacy - a real-world registry and biobank study. Neuropsychopharmacology 2024;49:1113-1119.
PMID: 38184734